Skip to main content
MAYNE PHARMA GROUP LIMITED logo

MAYNE PHARMA GROUP LIMITED — Investor Relations & Filings

Ticker · MYX ISIN · AU000000MYX0 LEI · 549300VIRDEN0N4MJG59 ASX Manufacturing
Open in API
Filings indexed 1,121 across all filing types
Latest filing 2016-12-11 Major Shareholding Noti…
Country AU Australia
Listing ASX MYX

About MAYNE PHARMA GROUP LIMITED

https://www.maynepharma.com

Mayne Pharma Group Limited is a specialty pharmaceutical company focused on the development and commercialization of branded and generic medicines. The company operates through specialized segments including Women's Health and Dermatology. Its Women's Health portfolio features innovative contraceptive solutions, while the Dermatology division provides a broad range of treatments for various skin conditions. Beyond its product portfolio, the company provides contract development and manufacturing services (CDMO), leveraging proprietary drug delivery technologies to produce complex oral and topical dosage forms. The organization focuses on high-growth specialty markets, aiming to deliver differentiated therapeutic options and improve patient outcomes through technical excellence and strategic commercialization.

Recent filings

Filing Released Lang Actions
Ceasing to be a substantial holder from NAB 15 pages 185.3KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 605 under the Corporations Act 2001, titled 'Notice of ceasing to be a substantial holder.' It details changes in relevant interests of a substantial holder in voting securities, including dates, nature of changes, and securities affected. It also includes appendices listing agreements and counterparties related to securities lending and borrowing. The document is regulatory in nature, reporting changes in shareholding and substantial holder status, which aligns with notifications of major shareholding changes. It is not a financial report, earnings release, or management report, but a formal notification of shareholding changes as required by regulation.
2016-12-11 English
Change of Director's Interest Notice 2 pages 49.6KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a director, including number of shares held before and after the change, nature of the interest, and transaction details. This matches the definition of a Director's Dealing report, which reports personal share transactions by company directors and executives (insider trades). The document is about a director's change in shareholding and is not an announcement of a report or a general regulatory filing. Therefore, the correct classification is DIRS.
2016-12-11 English
Change in substantial holding 3 pages 74.9KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 filed under the Corporations Act 2001 Section 671B, titled 'Notice of change of interests of substantial holder'. It details changes in voting power and relevant interests of a substantial shareholder, Mr Bruce Mathieson and related entities, in Mayne Pharma Group Limited. The document includes dates of changes, nature of changes (on-market purchase, rights issue), and voting power percentages. This type of filing is a notification of changes in significant share ownership levels, which corresponds to the category 'Major Shareholding Notification'. The document is not a financial report, earnings release, or management information, but a regulatory notice about shareholding changes.
2016-12-11 English
Appendix 3B 9 pages 330.1KB
Capital/Financing Update Classification · 100% confidence The document is an Appendix 3B form, which is a standard Australian Securities Exchange (ASX) announcement used for new issue announcements, applications for quotation of additional securities, and agreements related to securities issuance. It details the class and number of securities issued, issue price, purpose, and other related information. This type of document is specifically related to capital raising and changes in the company's capital structure. It is not a financial report, earnings release, or management discussion, but rather a formal announcement of a capital/financing event. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is not a mere announcement of a report but a substantive filing about securities issuance.
2016-12-08 English
Change of Director's Interest Notice 2 pages 41.9KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a director, including number of shares held before and after the change, nature of interest, and transaction details. This matches the definition of a Director's Dealing report, which reports personal share transactions by company directors and executives (insider trades). The document length is 4392 characters, which is sufficient to contain substantive details of the transaction, not just an announcement. Therefore, the correct classification is DIRS.
2016-12-06 English
Becoming a substantial holder from NAB 25 pages 553.9KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 603 under the Corporations Act 2001 Section 671B, titled 'Notice of initial substantial holder'. It details the substantial shareholding interests, voting power, relevant interests, registered holders, and consideration paid for shares by a substantial shareholder (National Australia Bank Limited and associated entities). This type of filing is a notification of changes in significant share ownership levels, which corresponds to a Major Shareholding Notification. The document is lengthy and contains detailed shareholding data, consistent with a major shareholding notice rather than a general regulatory filing or other report types.
2016-11-29 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.